<DOC>
	<DOCNO>NCT01100294</DOCNO>
	<brief_summary>To determine tolerability safety FLUVAL P monovalent influenza vaccine child .</brief_summary>
	<brief_title>Tolerability Safety Study FLUVAL P Monovalent Influenza Vaccine Children</brief_title>
	<detailed_description>This open , uncontrolled study ass safety tolerability Fluval P monovalent influenza vaccine ( whole virus , inactivate , adjuvanted alumn phosphate gel ) contain 6 mcgHA per 0.5mL active ingredient child 6-36 month age . The vaccination repeat . Tolerability safety ( incidence adverse event ) study drug assess Day 28 Day 180-210 follow vaccination .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Aluminum phosphate</mesh_term>
	<criteria>Children age 6 36 month , sex ; Are good health ( determine vital sign exist medical condition ) stable medical condition . Subjects exclude know adequately treat clinically significant organ systemic disease ( e.g . asthma diabetes ) , , opinion investigator , significance disease compromise subject 's participation study ; Capability legitimate representative volunteer understand comply plan study procedure ; Legitimate representative volunteer provide write informed consent prior initiation study procedure ; Absence existence exclusion criterion . Known allergy egg component vaccine ( particular mercury ) ; History GuillainBarr√© syndrome ; Active neoplasm ; Former ongoing immunosuppressive therapy ; Concomitant corticosteroid therapy , include highdose inhaled corticosteroid ; Immunoglobulin ( similar blood product ) therapy within 3 month prior vaccination ; Documented HIV , HBV HCV infection ; Chronic illness , opinion investigator , may effect participation study ; Acute febrile respiratory illness within one week prior vaccination ; Vaccine therapy within 4 week prior vaccination ; Influenza vaccination within 6 month prior vaccination ; Experimental drug therapy within 1 month prior vaccination ; Past current psychiatric disease legitimate representative upon judgement investigator may effect objective decisionmaking legitimate representative ; Alcohol drug abuse legitimate representative .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Pandemic vaccine</keyword>
	<keyword>Seasonal vaccine</keyword>
	<keyword>Prevention</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Influenza human</keyword>
	<keyword>Pandemic influenza human</keyword>
	<keyword>Influenza vaccine child</keyword>
</DOC>